🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨LIVE in 5 - Join Joshua Sabari, MD and Marcelo Negrao as they delve into the latest NSCLC data presented in Chicago! Calling all thoracic oncologists, surgeons and pulmonologists to join the discussion now on Medscape and earn CME credits!

Starting Now: Monotherapy Data with Agents Targeting KRAS G12C Mutations Moderated By: Dr. John Heymach MD Anderson Cancer Center #DAVAHawaiiLung

There is no shortage of novel KRAS G12C inhibitors! Marcelo Negrao highlights the unmet need of patients who do not respond to current therapies and shares the latest clinical data for olomorasib, which showed promise in patients who had failed a prior G12C inhibitor.

Starting Now: RAS Inhibitor Combinations Moderated by: Dr. John Heymach MD Anderson Cancer Center #DAVAHawaiiLung

Starting Now: Targeting RET/RAF/ROS-1/PRMT5 Moderated by: Misako Nagasaka #DAVAHawaiiLung

Starting Now: Novel Bispecifics, ADCs, and Radiation Sensitizers in Head and Neck Cancer Moderated by: Hossein Borghaei, DO #DAVAHawaiiLung

Starting Now: Translational Biology Moderated by: Robert Haddad #DAVAHawaiiLung

🔥Ph III KN867 trial of SBRT+concurrent/adjuvant pembrolizumab stopped early due to higher AEs in IO arm, &lack of EFS&OS benefit Important negative data, that will inform optimum timing of IO, & definitive tx modality Lets see the data OncoAlert #LCSM merck.com/news/merck-pro…

New #JITC article: Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer bit.ly/3NYsw3H Nicolas Zhou Humam Kadara Marcelo Negrao Boris Sepesi MD FACS

Our manuscript is out Clinical Cancer Research - great team work to improve #lcsm pt outcomes MD Anderson Cancer Center KRASKickers LungCancerRx 🫁💊 VJ Oncology David S. Hong MD Scott Kopetz Impact of co-mutations and transcriptional signatures in NSCLC patients treated with adagrasib aacrjournals.org/clincancerres/…

Dr. Marcelo Negrao takes the stage at #TexasLung25 to explore advanced NSCLC and the evolving role of HER-targeted therapies—ADC vs. TKI. Join us in Austin, April 10-12, for this expert discussion. Learn more about this 2-day #CE-accredited conference: hubs.ly/Q03934jK0 #LCSM

MD Anderson Cancer Center thoracic oncology team does #TexasLung25! TLC Conference #TinaCascone Stephen V Liu, MD

I am so grateful for this community that despite all challenge with the National Cancer Institute and FDA Oncology funding and changes they are willing to continue to fight for our patients and develop the line of treatments.

Thoroughly enjoyed #TexasLung25. A complete overview of thoracic oncology landscape. Thank you Stephen V Liu, MD Dr. Tina Cascone for your thoughtful organization of the meeting. Eric K. Singhi, MD Mara Antonoff, MD, FACS Narjust Florez, MD, FASCO Sandip Patel MD FASCO Dr. Estela Rodriguez Christian Rolfo Mary Jo Foley

Thank you to our incredible faculty for making #TexasLung25 a success! Your expertise, insightful discussions, and commitment to advancing lung cancer care were key to making this 2-day CE-accredited conference truly memorable. hubs.la/Q03hrM860

It was an honor and a pleasure to present research updates on targeting #kras G12C mutations to the The White Ribbon Project™ community. Thank you for everything you do to support patients and #lcsm research MD Anderson Cancer Center KRASKickers LUNGevity Foundation American Cancer Society

TY Marcelo Negrao for bringing #hope to the #lungcancer community. Your passion & innovation are transforming care, uplifting a long neglected community & giving us the most precious gift-time. #researchmatters #changingthepublicperceptionoflungcancer #TheWhiteRibbonProject

Thank you Young Lung Cancer Initiative for inviting me to participate on this education series. It’s always great to interact with patients and advocates especially when it’s about increasing awareness and discussing novel treatments for #kras #LCSM MD Anderson Cancer Center The White Ribbon Project™ KRASKickers

Tomorrow at #AACR25 Dr. Marcelo Negrao will present in the poster session, data from a phase 2 cohort of KRYSTAL-1. Outcomes will be shared from first-line KRAS G12C inhibitor in patients with advanced #NSCLC harboring KRAS G12C and STK11 mutations. #LCSM #lungcancer

Adagrasib Yields Early Efficacy in STK11- and KRAS G12C–Mutant NSCLC AACR #AACR25 #LCSM onclive.com/view/adagrasib…